Enlivex Therapeutics Stock Price History
ENLV Stock | USD 0.93 0.09 10.71% |
Below is the normalized historical share price chart for Enlivex Therapeutics extending back to July 31, 2014. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of Enlivex Therapeutics stands at 0.93, as last reported on the 25th of November, with the highest price reaching 0.93 and the lowest price hitting 0.83 during the day.
If you're considering investing in Enlivex Stock, it is important to understand the factors that can impact its price. Enlivex Therapeutics secures Sharpe Ratio (or Efficiency) of -0.0716, which denotes the company had a -0.0716% return per unit of risk over the last 3 months. Enlivex Therapeutics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please confirm Enlivex Therapeutics' Standard Deviation of 4.86, mean deviation of 3.33, and Variance of 23.61 to check the risk estimate we provide.
At this time, Enlivex Therapeutics' Common Stock is fairly stable compared to the past year. Preferred Stock Total Equity is likely to climb to about 10.2 M in 2024, whereas Treasury Stock is likely to drop (959.2 K) in 2024. . Price To Sales Ratio is likely to drop to 39.01 in 2024. Price Earnings Ratio is likely to drop to -1.81 in 2024. Enlivex Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 12th of December 1995 | 200 Day MA 1.8548 | 50 Day MA 1.3995 | Beta 1.105 |
Enlivex |
Sharpe Ratio = -0.0716
Best Portfolio | Best Equity | |||
Good Returns | ||||
Average Returns | ||||
Small Returns | ||||
Cash | Small Risk | Average Risk | High Risk | Huge Risk |
Negative Returns | ENLV |
Estimated Market Risk
4.87 actual daily | 43 57% of assets are more volatile |
Expected Return
-0.35 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
-0.07 actual daily | 0 Most of other assets perform better |
Based on monthly moving average Enlivex Therapeutics is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Enlivex Therapeutics by adding Enlivex Therapeutics to a well-diversified portfolio.
Price Book 0.6965 | Book Value 1.368 | Enterprise Value -5.2 M | Enterprise Value Ebitda (1.49) | Shares Float 15.6 M |
Enlivex Therapeutics Stock Price History Chart
There are several ways to analyze Enlivex Stock price data. The simplest method is using a basic Enlivex candlestick price chart, which shows Enlivex Therapeutics price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
Highest Price | October 16, 2024 | 1.69 |
Lowest Price | November 21, 2024 | 0.84 |
Enlivex Therapeutics November 25, 2024 Stock Price Synopsis
Various analyses of Enlivex Therapeutics' daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell Enlivex Stock. It can be used to describe the percentage change in the price of Enlivex Therapeutics from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of Enlivex Stock.Enlivex Therapeutics Price Rate Of Daily Change | 1.11 | |
Enlivex Therapeutics Price Daily Balance Of Power | 0.90 | |
Enlivex Therapeutics Price Action Indicator | 0.10 |
Enlivex Therapeutics November 25, 2024 Stock Price Analysis
Enlivex Stock Price History Data
The price series of Enlivex Therapeutics for the period between Tue, Aug 27, 2024 and Mon, Nov 25, 2024 has a statistical range of 0.85 with a coefficient of variation of 14.04. Under current investment horizon, the daily prices are spread out with arithmetic mean of 1.37. The median price for the last 90 days is 1.45. The company completed 1:8 stock split on 6th of March 2019. Enlivex Therapeutics completed dividends distribution on 2019-03-06.Open | High | Low | Close | Volume | ||
11/25/2024 | 0.83 | 0.93 | 0.83 | 0.93 | ||
11/22/2024 | 0.83 | 0.93 | 0.83 | 0.93 | 221,613 | |
11/21/2024 | 1.00 | 1.02 | 0.81 | 0.84 | 427,729 | |
11/20/2024 | 1.06 | 1.11 | 0.93 | 0.98 | 388,174 | |
11/19/2024 | 1.03 | 1.06 | 1.01 | 1.03 | 60,389 | |
11/18/2024 | 1.06 | 1.09 | 1.00 | 1.05 | 198,590 | |
11/15/2024 | 1.09 | 1.10 | 1.01 | 1.07 | 132,493 | |
11/14/2024 | 1.16 | 1.17 | 1.08 | 1.08 | 158,628 | |
11/13/2024 | 1.21 | 1.21 | 1.13 | 1.18 | 116,463 | |
11/12/2024 | 1.20 | 1.23 | 1.17 | 1.20 | 115,147 | |
11/11/2024 | 1.27 | 1.27 | 1.15 | 1.20 | 212,477 | |
11/08/2024 | 1.25 | 1.29 | 1.21 | 1.23 | 92,194 | |
11/07/2024 | 1.27 | 1.31 | 1.21 | 1.27 | 160,967 | |
11/06/2024 | 1.31 | 1.33 | 1.21 | 1.27 | 131,971 | |
11/05/2024 | 1.29 | 1.32 | 1.24 | 1.29 | 144,037 | |
11/04/2024 | 1.41 | 1.43 | 1.22 | 1.30 | 209,368 | |
11/01/2024 | 1.35 | 1.41 | 1.30 | 1.36 | 92,412 | |
10/31/2024 | 1.40 | 1.41 | 1.27 | 1.35 | 270,433 | |
10/30/2024 | 1.47 | 1.47 | 1.36 | 1.38 | 140,332 | |
10/29/2024 | 1.45 | 1.48 | 1.41 | 1.43 | 89,230 | |
10/28/2024 | 1.50 | 1.59 | 1.43 | 1.48 | 162,936 | |
10/25/2024 | 1.55 | 1.65 | 1.41 | 1.47 | 275,489 | |
10/24/2024 | 1.60 | 1.61 | 1.45 | 1.52 | 255,780 | |
10/23/2024 | 1.54 | 1.55 | 1.45 | 1.49 | 288,091 | |
10/22/2024 | 1.55 | 1.58 | 1.45 | 1.47 | 172,757 | |
10/21/2024 | 1.62 | 1.63 | 1.49 | 1.53 | 214,961 | |
10/18/2024 | 1.68 | 1.71 | 1.51 | 1.52 | 173,689 | |
10/17/2024 | 1.70 | 1.71 | 1.60 | 1.63 | 171,201 | |
10/16/2024 | 1.63 | 1.75 | 1.60 | 1.69 | 368,315 | |
10/15/2024 | 1.46 | 1.56 | 1.45 | 1.55 | 74,006 | |
10/14/2024 | 1.43 | 1.52 | 1.43 | 1.45 | 68,378 | |
10/11/2024 | 1.47 | 1.49 | 1.38 | 1.46 | 32,414 | |
10/10/2024 | 1.53 | 1.59 | 1.43 | 1.49 | 45,414 | |
10/09/2024 | 1.46 | 1.56 | 1.46 | 1.54 | 12,923 | |
10/08/2024 | 1.53 | 1.55 | 1.45 | 1.48 | 35,455 | |
10/07/2024 | 1.54 | 1.60 | 1.48 | 1.53 | 32,190 | |
10/04/2024 | 1.63 | 1.63 | 1.52 | 1.59 | 36,310 | |
10/03/2024 | 1.55 | 1.62 | 1.55 | 1.58 | 19,862 | |
10/02/2024 | 1.59 | 1.59 | 1.55 | 1.55 | 31,692 | |
10/01/2024 | 1.68 | 1.69 | 1.56 | 1.61 | 52,401 | |
09/30/2024 | 1.62 | 1.75 | 1.62 | 1.68 | 106,843 | |
09/27/2024 | 1.59 | 1.71 | 1.58 | 1.64 | 196,610 | |
09/26/2024 | 1.49 | 1.60 | 1.47 | 1.58 | 126,457 | |
09/25/2024 | 1.50 | 1.50 | 1.44 | 1.46 | 40,135 | |
09/24/2024 | 1.50 | 1.54 | 1.40 | 1.48 | 77,899 | |
09/23/2024 | 1.51 | 1.52 | 1.36 | 1.48 | 154,582 | |
09/20/2024 | 1.55 | 1.57 | 1.44 | 1.51 | 68,169 | |
09/19/2024 | 1.60 | 1.65 | 1.45 | 1.50 | 298,435 | |
09/18/2024 | 1.60 | 1.74 | 1.53 | 1.55 | 355,721 | |
09/17/2024 | 1.57 | 1.70 | 1.42 | 1.51 | 265,138 | |
09/16/2024 | 1.60 | 1.65 | 1.50 | 1.54 | 182,002 | |
09/13/2024 | 1.61 | 1.76 | 1.53 | 1.57 | 424,491 | |
09/12/2024 | 1.34 | 1.64 | 1.29 | 1.59 | 592,044 | |
09/11/2024 | 1.29 | 1.32 | 1.26 | 1.31 | 107,605 | |
09/10/2024 | 1.19 | 1.27 | 1.19 | 1.27 | 41,746 | |
09/09/2024 | 1.20 | 1.24 | 1.20 | 1.20 | 18,926 | |
09/06/2024 | 1.27 | 1.27 | 1.22 | 1.27 | 4,044 | |
09/05/2024 | 1.20 | 1.23 | 1.20 | 1.23 | 17,003 | |
09/04/2024 | 1.24 | 1.29 | 1.22 | 1.23 | 27,993 | |
09/03/2024 | 1.25 | 1.27 | 1.22 | 1.26 | 17,787 | |
08/30/2024 | 1.22 | 1.30 | 1.21 | 1.30 | 25,699 |
About Enlivex Therapeutics Stock history
Enlivex Therapeutics investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Enlivex is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Enlivex Therapeutics will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Enlivex Therapeutics stock prices may prove useful in developing a viable investing in Enlivex Therapeutics
Last Reported | Projected for Next Year | ||
Common Stock Shares Outstanding | 18.6 M | 19.5 M | |
Net Loss | -28 M | -26.6 M |
Enlivex Therapeutics Quarterly Net Working Capital |
|
Enlivex Therapeutics Stock Technical Analysis
Enlivex Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run FinTech Suite Now
FinTech SuiteUse AI to screen and filter profitable investment opportunities |
All Next | Launch Module |
Enlivex Therapeutics Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for Enlivex Therapeutics' price direction in advance. Along with the technical and fundamental analysis of Enlivex Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Enlivex to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
Risk Adjusted Performance | (0.05) | |||
Jensen Alpha | (0.42) | |||
Total Risk Alpha | (1.16) | |||
Treynor Ratio | (1.81) |
Cycle Indicators | ||
Math Operators | ||
Math Transform | ||
Momentum Indicators | ||
Overlap Studies | ||
Pattern Recognition | ||
Price Transform | ||
Statistic Functions | ||
Volatility Indicators | ||
Volume Indicators |
Additional Tools for Enlivex Stock Analysis
When running Enlivex Therapeutics' price analysis, check to measure Enlivex Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Enlivex Therapeutics is operating at the current time. Most of Enlivex Therapeutics' value examination focuses on studying past and present price action to predict the probability of Enlivex Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Enlivex Therapeutics' price. Additionally, you may evaluate how the addition of Enlivex Therapeutics to your portfolios can decrease your overall portfolio volatility.